Notably, unlike previous work that has focused predominantly on amyloid-based models, our study reveals a direct role for m6A in modulating tau pathology, which is particularly important because tau burden shows a stronger correlation with cognitive decline in AD65. This evidence concerns the gene MAPT and Mental deterioration.